Page 1407 - Health News

Coronavirus India dispatch: What are the Covid-19 endgame scenarios?

A roundup of articles in Indian news publications on how India is dealing with the Covid-19 pandemic

Madhya Pradesh CM Shivraj Singh Chouhan tests positive for coronavirus

The chief minister said that if detected and treated on time, Covid-19 infection can be cured

Coronavirus vaccine update: Chinese vaccine shows promise in animal tests

There are 23 coronavirus vaccine candidates in human trials, including Moderna, AstraZeneca Plc, BioNTech, Novavax, Sinovac, CanSino Biologics and Inovio. Catch latest updates on Covid-19 vaccine

Want to volunteer for a coronavirus vaccine trial? Things you should know

With the studies entering human trial phase, a critical requirement is to select volunteers who are willing to participate

Covid-19 Factoid: India has seen more than 5,000 deaths in just 7 days

Andhra Pradesh, which has seen a sudden surge in cases, added almost 8,000 new cases on July 23, taking its overall cases tally to almost 73,000

IFC to back BioE Ltd's pipeline of vaccines, including for Covid-19

The company will raise $30 mn from IFC to support the proposed expansion plan for its pipeline of vaccines and pharma products, besides playing a role in expediting Covid-19 vaccine development

Coronavirus LIVE updates: Delhi's recovery rate improves to over 86%

Coronavirus latest news: Maharashtra now has 357,502 cases, Tamil Nadu 192,964, Delhi 127,364, and Karnataka 80,863. Stay tuned for coronavirus LIVE updates

Biggest single-day jump of over 284,000 global cases in last 24 hours

Deaths rose by 9,753, the biggest one-day increase since a record high of 9,797 deaths on April 30.

Covid-19 vaccine human trial: Man given first dose of Covaxin at AIIMS

Already, over 3,500 volunteers have registered themselves for the trial at AIIMS since last Saturday

Covid-19: Boris Johnson accepts he could have done things differently

He has pledged to hold an inquiry into his handling of the coronavirus crisis but not yet.

India coronavirus dispatch: The next phase needs less fear, more governance

A roundup of articles in Indian news publications on how India is dealing with the Covid-19 pandemic.

Jenburkt Pharma launches Covid-19 drug Favipiravir at Rs 39 per tablet

The company hopes that the easy accessibility and affordable price point of an effective treatment such as Favivent will offer Indian citizens a timely, much-needed therapeutic solution

Covid-19: Testing times for plasma banks as demand goes through the roof

The first of a two-part series looks at challenges involved in plasma therapy

IIT Delhi, Wells Fargo sign MoU for home-based Covid-19 testing kit

The peptide-based ELISA test determines whether or not a person possesses antibodies for Covid-19 in the blood, and can help the medical fraternity fight the disease in many ways

Cipla gets DCGI approval to sell Covid-19 drug favipiravir in India

Cipla said it would launch favipiravir as "Ciplenza" in the first week of August, priced at 68 Indian rupees (91 cents) per 200 mg tablet

Tamil Nadu adds 6,785 new Covid-19 cases, state's total tally at 199,749

63,182 persons were tested in the last 24 hours, which is the highest so far

Covid-19 lockdown: No flight operations at Kolkata airport on July 25, 29

According to the West Bengal airport sources, no passenger flights will be operated on July 25 and 29 from the Kolkata airport during the lockdown in the state

India's Covid-19 fatality rate drops to 2.38%; recovery rate up at 63.34%

India also saw a record single-day spike of 49,310 cases while the death-toll mounted to 30,601 with 740 new fatalities, the data said

Most people in India not comfortable travelling for at least a year: Survey

"While the tourism industry has started to make a comeback in a big way in Europe; in India, the current signals are bleak," Neta App founder Pratham Mittal said

China's Covid-19 vaccine candidate shows some promise in animal tests

It is the second potential Covid-19 vaccine that China's military-backed research unit has moved into clinical trials